Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Baby’s first breath: How one landmark program in China has saved 150,000 newborns
Helping Babies Breath Hi Res

Baby’s first breath: How one landmark program in China has saved 150,000 newborns

Sixty seconds. That’s how much time a healthcare professional has to ensure that a newborn takes a first breath in order for that baby to have a healthy start in life.

But far too often newborns aren’t able to take that first breath on their own.

It’s a condition known as birth asphyxia—and it’s one of the world’s leading causes of infant mortality. In fact, some 10 million newborns worldwide have difficulty breathing at birth each year. And in China, over 73,000 babies died from the complication in 2004 alone.

So to help change that alarming statistic, Johnson & Johnson formed a first-of-its-kind public-private partnership with the Chinese government and other professional associations to launch the “Freedom of Breath, Fountain of Life” training program.

The goal: help prevent birth asphyxia in Chinese hospitals by ensuring that every delivery had at least one person trained in neonatal resuscitation present.

Today, as the program marks its 10-year anniversary, the initiative has saved an estimated 150,000 newborns across the country.

And that’s just one heartwarming stat.

As you’ll see in this infographic, there are more inspiring facts, figures and stories behind the formation of this landmark partnership—and the many children to whom it’s given a healthy start.

Cina NRP Final Infographic

null

More from Johnson & Johnson

6 ways Johnson & Johnson is using AI to help advance healthcare

Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.

Johnson & Johnson named to Fortune’s 2026 America’s Most Innovative Companies list

The company’s dedication to advancing solutions for the world’s most pressing health challenges has once again earned it a place on this annual ranking.

Meet a nurse who leads clinical trials to find innovative cancer therapies

Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.